Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination

Completed · Phase 2 · Has a placebo group

Conditions studied: Influenza

In brief

Immunogenicity and safety of a cell-derived influenza vaccine in adults aged \>= 18 and \<= 64 years, plus revaccination

Key facts

Study ID

NCT00889889

Run by

Abbott Biologicals

People needed

1270

Starts

2009-05-01

Expected to finish

2011-01-01

Last updated by the study team

2013-10-25

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Willing and able to give informed consent and able to adhere to all protocol required study procedures.
• Men and women aged >= 18 and <= 64 years.
• Being in good health as judged by medical history, physical examination and clinical judgment of the investigator.

You may not qualify if…

• Known to be allergic to constituents of the vaccine.
• A serious adverse reaction after a previous (influenza) vaccination. Presence of any significant condition that may prohibit inclusion as determined by the investigator.
• Having received vaccination against influenza or lab confirmed influenza within the previous six months before study vaccination.

Where it is running

• Site Reference ID/Investigator# 45690 — Jacksonville, Florida, United States
• Site Reference ID/Investigator# 45687 — Pembroke Pines, Florida, United States
• Site Reference ID/Investigator# 45697 — South Miami, Florida, United States
• Site Reference ID/Investigator# 45691 — Lenexa, Kansas, United States
• Site Reference ID/Investigator# 45689 — Overland Park, Kansas, United States
• Site Reference ID/Investigator# 45694 — Wichita, Kansas, United States
• Site Reference ID/Investigator# 45682 — Lexington, Kentucky, United States
• Site Reference ID/Investigator# 45684 — Kansas City, Missouri, United States
• Site Reference ID/Investigator# 45685 — Omaha, Nebraska, United States
• Site Reference ID/Investigator# 45686 — Las Vegas, Nevada, United States
• Site Reference ID/Investigator# 45688 — Raleigh, North Carolina, United States
• Site Reference ID/Investigator# 45696 — Nashville, Tennessee, United States
• Site Reference ID/Investigator# 45683 — Austin, Texas, United States
• Site Reference ID/Investigator# 45695 — Fort Worth, Texas, United States
• Site Reference ID/Investigator# 45692 — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.